CDMO Playbook for Scaling the Emerging Biotech Companies
Summary: Biotech startups often emerge from scientific innovation but navigating the often decade-plus journey from laboratory to pharmacy ultimately requires much more. While a drug or molecule may seem to hold promise, roughly 90% of all biotechs fail to place their product into the hands of doctors and patients. In this eBook, learn more about strategies that successful emerging biopharma and biotech companies have used along with their CDMO partners to move their discovery to market.